MiRXES&rsquo; patented reverse transcription (RT)-quantitative polymerase chain reaction (qPCR) technology platform enables sensitive, specific, and robust detection of microRNAs and other non-coding RNAs in biofluids and tissue samples.

MiRXES

Singapore City

MiRXES startup from Singapore City, Singapore is ranked 1295 out of 2449 worldwide and 21 from the 35 startups in Singapore. See more information and additional rankings on the StartupBlink Global Ecosystem Map